1. Home
  2. LOMA vs SLN Comparison

LOMA vs SLN Comparison

Compare LOMA & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

LOMA

Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

HOLD

Current Price

$9.45

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

SELL

Current Price

$19.65

Market Cap

1.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LOMA
SLN
Founded
1926
1994
Country
Argentina
United Kingdom
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
LOMA
SLN
Price
$9.45
$19.65
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$14.30
★ $33.00
AVG Volume (30 Days)
462.9K
★ 3.8M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 1.01%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $559,000.00
Revenue This Year
$23.53
N/A
Revenue Next Year
$10.89
$130.93
P/E Ratio
$187.97
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$7.87
$4.19
52 Week High
$13.20
$19.67

Technical Indicators

Market Signals
Indicator
LOMA
SLN
Relative Strength Index (RSI) 40.88 79.32
Support Level $8.92 $4.97
Resistance Level $12.10 N/A
Average True Range (ATR) 0.35 0.49
MACD -0.01 1.31
Stochastic Oscillator 12.00 99.77

Price Performance

Historical Comparison
LOMA
SLN

About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The Group is engaged in the production and distribution of cement, masonry cement, concrete, limestone, and aggregates, operates a railway concession to provide transportation services, and is also engaged in the industrial waste recycling business. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: